Selected article for: "common cold and parallel group trial"

Author: Yan, Bohua; Jiang, Zhiwei; Yuan, Jing; Li, Minghui; Zeng, Jieping; Tang, Jianyuan; Lu, Kevin; Ding, Hong; Xia, Jielai; Wang, Qiaoling; Wang, Jundong; Xie, Hongyan; Li, Wenyuan; Zhang, Na; Li, Haiyan; Sang, Xiaoya; Wu, Lina; Xiong, Xiaomo; Tang, Shiyun; Li, Yan; Tao, Mengyao; Xie, Chunguang; Yu, Shuguang
Title: Effects and Safety of Herbal Medicines among Community-dwelling Residents during COVID-19 Pandemic: A Large Prospective, Randomized Controlled Trial (RCT)
  • Cord-id: 2snsstie
  • Document date: 2020_11_5
  • ID: 2snsstie
    Snippet: BACKGROUND: : Since the declaration of COVID-19 as a global pandemic by the World Health Organization, countries are struggling with a shortage of medical capacities. It would be essential if the risk for preventable comorbidities, such as the common cold, can be reduced or prevented, so that the scarce medical resources and facilities can be focused on COVID-19. PURPOSE: : To evaluate the effects of two herbal medicines (Jinhao artemisia antipyretic granules and Huoxiangzhengqi oral liquids) in
    Document: BACKGROUND: : Since the declaration of COVID-19 as a global pandemic by the World Health Organization, countries are struggling with a shortage of medical capacities. It would be essential if the risk for preventable comorbidities, such as the common cold, can be reduced or prevented, so that the scarce medical resources and facilities can be focused on COVID-19. PURPOSE: : To evaluate the effects of two herbal medicines (Jinhao artemisia antipyretic granules and Huoxiangzhengqi oral liquids) in reducing the risk of the common cold in community-dwelling residents in China during the COVID-19 outbreak. STUDY DESIGN: : An open-label, parallel-group, controlled, cluster-randomized trial, was conducted in Chengdu, China. METHODS: : A total of 22,065 participants from 11 communities were recruited during a period of 1 month. The trial started on 30 January and participants were followed up till 29 February 2020. Participants were randomly assigned to receive either a five-day herbal medicine therapy plus a reference manual for Health Infection Prevention and Control or the reference manual if they were allocated to the control group. The primary endpoint was the occurrence of patient-reported common cold symptoms. The secondary endpoint was the time in days from the receipt of herbal drugs/reference manual and the occurrence of the common cold symptoms. RESULTS: : Use of herbal medicine reduced the risk of the common cold by 89.6% (95% CI, 52.9% to 97.7%) in all community-dwelling residents, and by 94.0% (95% CI, 52.1% to 99.2%) in residents aged between 16 and 59 years old. Sensitivity analyses showed similar results. CONCLUSION: : This community-based RCT found that the use of a herbal medicine therapy (Jinhao artemisia antipyretic granules and Huoxiangzhengqi oral liquids) could significantly reduce the risks of the common cold among community-dwelling residents, suggesting that herbal medicine may be a useful approach for public health intervention to minimize preventable morbidity during COVID-19 outbreak.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver test and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abnormal liver test and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal liver test and liver injury: 1, 2, 3, 4, 5, 6
    • abnormal liver test and liver test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • liver function and low incidence: 1, 2, 3, 4
    • lmics middle income country and low lmics middle income country: 1, 2